MetaCap

Who Owns Oncolytics Biotech Stock?

NASDAQ: ONCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.557+0.0126 (+2.31%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 0.569 +2.15%

Ownership breakdown

Held by institutions
3.21%
Institutional holders
83
  • Institutions 3.2%
  • Insiders 2.0%
  • Public and other 94.8%

Who owns Oncolytics Biotech stock?

Institutional investors own about 3.2% of Oncolytics Biotech's shares, spread across 83 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.99% of ONCY.

The largest institutional holders are Marshall Wace LLP (0.57%), Xtx Topco Ltd (0.20%) and Seeds Investor LLC (0.20%). Together, the top 10 institutions control 1.8% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ONCY positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of ONCY

Oncolytics Biotech top institutional holders
InstitutionShares% HeldChange
Marshall Wace LLP745.35K0.57%-13.3%
Xtx Topco Ltd260.90K0.20%+137.7%
Seeds Investor LLC 258.31K0.20%0.0%
International Assets Investment Management, LLC201.26K0.15%+100.0%
Connective Capital Management LLC185.71K0.14%+100.0%
Goldman Sachs Group Inc169.90K0.13%+100.0%
Tocqueville Asset Management L.p.147.00K0.11%-1.3%
Everhart Financial Group, Inc.140.90K0.11%+2.0%
Susquehanna International Group, LLP134.13K0.10%+224.6%
Pfg Investments, LLC 128.30K0.10%+142.5%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of ONCY

Oncolytics Biotech top fund holders
FundShares% Held
Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF107.52K0.08%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund66.94K0.05%
Victory Portfolios III-Victory Extended Market Index Fund13.51K0.01%

Frequently asked questions

Who is the largest shareholder of Oncolytics Biotech?

Marshall Wace LLP is the largest institutional shareholder of ONCY, owning 0.57% of shares outstanding (745.35K shares) as of its latest 13F filing.

What percentage of Oncolytics Biotech is owned by institutions?

Institutions own about 3.2% of ONCY shares and 3.3% of the public float.

How much of Oncolytics Biotech do insiders own?

Insiders, such as officers and directors, own about 1.99% of ONCY shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related